HC Wainwright Issues Pessimistic Outlook for PVLA Earnings
Palvella Therapeutics (NASDAQ:PVLA – Free Report) – HC Wainwright cut their Q1 2025 EPS estimates for shares of Palvella Therapeutics in a research report issued on Tuesday, April 1st. HC Wainwright analyst A. Fein now forecasts that the company will post earnings of ($3.56) per share for the quarter, down from their previous estimate of […]
Palvella Therapeutics (NASDAQ:PVLA – Free Report) – HC Wainwright cut their Q1 2025 EPS estimates for shares of Palvella Therapeutics in a research report issued on Tuesday, April 1st. HC Wainwright analyst A. Fein now forecasts that the company will post earnings of ($3.56) per share for the quarter, down from their previous estimate of […]
